Ranbaxy Laboratories News
Ranbaxy: Generic Lipitor Producer's Plant Shuts Down
FDA is monitoring recall after glass particles were found in bottles of a generic version of Lipitor.
Generic Lipitor Production Halted to Clear Glass From Capsules
Ranbaxy Pharmaceuticals Inc., the company that makes a generic version of the cholesterol-controlling medicine Lipitor, has agreed to stop producing the drug because it is unable to explain why some of the capsules are laced with tiny pieces of glass. Millions of Americans take Lipitor and its
Generic Lipitor Warning: Manufacturer Halts Production of Drug
David Kerley looks into production problems in generic form of cholesterol drug.
Senators Pan Pfizer’s Plan to Block Generic Lipitor
Pfizer’s plan to persuade health insurance and benefits companies to block prescriptions of generic versions of Lipitor has three senators crying foul. The patent on Lipitor, the cholesterol-lowering drug, or statin, that earned Pfizer more than $5.3 billion in annual U.S. sales, has now ...
Consumers Will Pay Half as Much for Generic Version of Lipitor
Angus Hepburn, of Beacon, N.Y., has been taking Lipitor, a cholesterol-lowering drug, since 2009, after he had a heart attack. He credits the drug with helping him bring his cholesterol level down to a healthy level. "I had blood work done yesterday, and my cholesterol levels are looking good," he
Lipitor Among Top Drugs Coming Off Patent
There could soon be some good news for consumers weary of soaring health care costs : The patents for several best-selling medications will expire this year, clearing the path for lower-cost generics to take their place. According to IBIS World, an industry research firm, some of the blockbuster
Health Highlights: May 5, 2009
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: No Higher Premiums for Women: Health Insurers American health insurers say they'll stop charging women higher premiums, a move seen as part of the industry's attempts to prevent creation of a
Health Highlights: May 4, 2009
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Ranbaxy Announces U.S. Recall of Antibiotic A U.S.-wide recall of an antibiotic used to treat urinary tract infections has been announced by India-based drug maker Ranbaxy. The recall of
FDA Halts New Applications From Indian Drug Maker's Plant
WEDNESDAY, Feb. 25 (HealthDay News) -- U.S. health officials have halted the review of any new drug applications from a Ranbaxy Laboratories plant in India after determining the facility was falsifying scientific data. Ranbaxy, based in India, is one of the largest suppliers of generic drugs to the
Health Highlights: Oct. 22, 2008
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Serious Drug-Reaction Reports Hit Record High A record number of serious drug-reaction reports were submitted to the U.S. Food and Drug Administration during the first quarter of this year, according